Published in J Clin Invest on October 01, 1992
The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev (2007) 6.79
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol (2010) 1.39
Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest (1997) 1.28
Enhanced sensitivity of Kv channels to hypoxia in the rabbit carotid body in heart failure: role of angiotensin II. J Physiol (2006) 1.26
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest (1995) 1.24
The adipose renin-angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal renin-angiotensin system. J Biomed Biotechnol (2006) 1.04
Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart (1997) 0.90
Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter. J Clin Invest (1994) 0.87
Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies. Heart Fail Rev (2007) 0.85
Losartan chemistry and its effects via AT1 mechanisms in the kidney. Curr Med Chem (2009) 0.85
Effects of exercise training on circulating and skeletal muscle renin-angiotensin system in chronic heart failure rats. PLoS One (2014) 0.84
Adaptive and genetic alterations of the renin angiotensin system in cardiac hypertrophy and failure. Basic Res Cardiol (1996) 0.79
Feedback mechanisms for cardiac-specific microRNAs and cAMP signaling in electrical remodeling. Circ Arrhythm Electrophysiol (2015) 0.78
New concepts regarding events that lead to end-stage heart disease. Cardiovasc Drugs Ther (1995) 0.75
Reciprocal change in angiotensinogen mRNA expression in rat myocardium and liver after myocardial infarction. Heart Vessels (1998) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Myocardial infarct size and ventricular function in rats. Circ Res (1979) 4.33
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A (1988) 3.21
Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol (1977) 2.39
In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest (1990) 2.29
Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest (1990) 1.99
Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Invest (1984) 1.93
Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation (1985) 1.92
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation (1981) 1.90
Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest (1986) 1.79
Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest (1986) 1.73
Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol (1986) 1.69
Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proc Natl Acad Sci U S A (1986) 1.62
Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol (1973) 1.59
Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function. Circ Res (1981) 1.55
Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest (1989) 1.42
The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest (1976) 1.37
The kidney in heart failure. N Engl J Med (1977) 1.34
Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol (1988) 1.33
Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res (1988) 1.24
Angiotensin II in arterial and renal venous plasma and renal lymph in the dog. J Clin Invest (1971) 1.15
Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res (1981) 1.11
Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res (1984) 1.08
Renal and circulatory mechanisms in congestive heart failure. Kidney Int (1987) 0.96
The feedback regulation of angiotensinogen production by components of the renin-angiotensin system. Circ Res (1983) 0.96
Neurohumoral responses to chronic myocardial infarction in rats. Circulation (1988) 0.95
The intrarenal renin-angiotensin-system. An immunocytochemical study on the localization of renin, angiotensinogen, converting enzyme and the angiotensins in the kidney of mouse and rat. Klin Wochenschr (1982) 0.95
Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension (1990) 0.94
Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics. Am J Cardiol (1987) 0.87
Angiotensinogen's role in ANG formation, renin release, and renal hemodynamics in isolated perfused kidney. Am J Physiol (1989) 0.86
Cardiorenal hemodynamics and sodium excretion in rats with myocardial infarction. Am J Physiol (1983) 0.85
Heart failure, renal function, and angiotensin converting enzyme inhibitors. Kidney Int Suppl (1987) 0.83
Captopril restores hemodynamic responsiveness to atrial natriuretic peptide in rats with heart failure. Circulation (1989) 0.82
Attenuated response to atrial natriuretic peptide in rats with myocardial infarction. Am J Physiol (1989) 0.81
Induction of angiotensinogen mRNA in hepatocytes by angiotensin II and glucocorticoids. Clin Exp Hypertens A (1988) 0.81
Role of the kidney in congestive heart failure. Acta Med Scand Suppl (1986) 0.78
Sodium balance effects on renin, angiotensinogen, and atrial natriuretic polypeptide mRNA levels. Am J Physiol (1988) 0.77
Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell (1991) 9.99
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
The emerging concept of vascular remodeling. N Engl J Med (1994) 4.27
Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med (1983) 3.63
Characterization of human prorenin expressed in mammalian cells from cloned cDNA. Proc Natl Acad Sci U S A (1986) 3.60
High-throughput genotyping with single nucleotide polymorphisms. Genome Res (2001) 3.55
Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res (2001) 3.07
Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res (2001) 2.98
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest (1990) 2.69
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet (1995) 2.52
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature (1995) 2.51
Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med (1997) 2.44
Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int (2007) 2.39
L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest (1992) 2.35
In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest (1990) 2.29
Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol (1992) 2.20
Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med (1980) 2.15
Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A (1995) 2.14
Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest (1992) 2.13
A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet (1995) 2.10
Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest (1989) 2.10
Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation (1991) 2.07
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest (1990) 2.07
Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol (1999) 2.02
Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci U S A (1993) 1.94
Reaction of aortic lysyl oxidase with beta-aminopropionitrile. J Biol Chem (1983) 1.90
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation (1981) 1.90
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int (2006) 1.88
Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem (1993) 1.87
Further defining housekeeping, or "maintenance," genes Focus on "A compendium of gene expression in normal human tissues". Physiol Genomics (2001) 1.85
Minority and nonminority pediatricians' care of minority and poor children. Arch Pediatr Adolesc Med (2000) 1.83
Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest (1991) 1.82
The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A (1995) 1.82
Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation (1994) 1.79
Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest (1986) 1.79
Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A (1997) 1.78
Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation (1995) 1.74
Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. J Clin Invest (1995) 1.71
A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci U S A (1995) 1.71
Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest (1993) 1.66
Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation (2001) 1.62
Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A (1996) 1.61
Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension (1999) 1.60
L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res (1990) 1.55
Therapeutic applications of transcription factor decoy oligonucleotides. J Clin Invest (2000) 1.53
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet (1999) 1.53
Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol (1997) 1.52
Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation (1996) 1.51
The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens (1999) 1.51
Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. N Engl J Med (1984) 1.49
Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol (1993) 1.48
Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest (1994) 1.48
Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation (1998) 1.46
Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells. Kidney Int (2006) 1.46
Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res (1991) 1.43
Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest (1989) 1.42
Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem (1997) 1.41
Significance of the vascular renin-angiotensin pathway. Hypertension (1986) 1.40
Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun (1992) 1.37
Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest (1998) 1.37
Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol (2001) 1.36
Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J Biol Chem (1999) 1.33
Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J Clin Invest (1993) 1.33
A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues. Endocrinology (1987) 1.33
Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension (1989) 1.31
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest (1990) 1.31
Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol (1997) 1.29
Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol (1987) 1.29
Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains. Hypertension (1986) 1.29
In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am J Physiol (1994) 1.25
A biometrical genome search in rats reveals the multigenic basis of blood pressure variation. Genome Res (1995) 1.23
Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation (1994) 1.22
Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling. Circulation (1993) 1.22
Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. J Thorac Cardiovasc Surg (2001) 1.21
Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technic for determination of inulin and para-aminohippurate. N Engl J Med (1972) 1.20
Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J Clin Invest (1993) 1.17
Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats : possible role in renoprotection. Hypertension (2000) 1.17
Binding of radioiodinated human von Willebrand factor to Bernard-Soulier, thrombasthenic and von Willebrand's disease platelets. Thromb Res (1981) 1.16
Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension (1992) 1.16
Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth. J Clin Invest (1999) 1.15
Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res (1999) 1.15
LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression. Proc Natl Acad Sci U S A (2000) 1.15
Renin expression by vascular endothelial cells in culture. Circ Res (1985) 1.14
Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest (1994) 1.13
Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol (1994) 1.13
Alterations in contractility and intracellular Ca2+ transients in isolated bundles of skeletal muscle fibers from rats with chronic heart failure. Circ Res (1993) 1.11
Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest (1993) 1.10
Albuminuria and peripheral arterial disease: results from the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis (2008) 1.10
Negative control elements and cAMP responsive sequences in the tissue-specific expression of mouse renin genes. Proc Natl Acad Sci U S A (1989) 1.09
Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest (1994) 1.09